FindTrial
Sign In

To evaluate reduction in number of lesions in disseminated cysticercosis after 2 weeks of albendazole with whole body MRI -A Pilot Study

Lesion reduction on whole body MRI in disseminated cysticercosis after 2 weeks of albendazole -A Pilot Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024815
Enrollment
40
Registered
2020-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere Health Condition 2: B608- Other specified protozoal diseases

Interventions

Intervention1: Albendazole Therapy: Albendazole 15mg/kg in two divided doses daily for 14 days. Three days prior to albendazole, patients will be primed with oral methylprednisolone(0.75-1mg/kg) and w

Sponsors

Kinzang Wangda
Lead Sponsor
Dr Neeraj Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: All the cases of disseminated cyscticercosis. Patients of neurocysticercosis will be diagnosed on the basis of Del Brutto criteria. Disseminated cysticercosis will be diagnosed as presence of multiple, (three or more than three) cystic viable lesions in the brain along with involvement of an additional extra site.

Exclusion criteria

Exclusion criteria: Patient in cysticercal encephalitis. The patients having evidence of systemic illness such as primary malignancy,HIV,Hepatitis B and C virus, pulmonary and systemic tuberculosis. Patients/ attendants refusing consent.

Design outcomes

Primary

MeasureTime frame
To evaluate reduction in number of cysticercus lesions after 2 weeks of albendazole.Timepoint: Three months—

Secondary

MeasureTime frame
To evaluate for symptomatic improvement after the therapy.Timepoint: patients will be followed up on monthly basis.—

Countries

India

Contacts

Public ContactDr Neeraj Kumar

King Georges Medical University

drneeraj2903@gmail.com9450357392

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026